Skip to main navigation
Skip to search
Skip to main content
Universidad Andrés Bello Home
Español
English
Search content at Universidad Andrés Bello
Home
Profiles
Research units
Projects
Research output
Datasets
Prizes
Activities
Press/Media
Impacts
Student theses
Treatment of Multisystem Inflammatory Syndrome in Children
BATS Consortium
Life Sciences School
Universidad Andrés Bello
Research output
:
Contribution to journal
›
Article
›
peer-review
290
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of Multisystem Inflammatory Syndrome in Children'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Multisystem Inflammatory Syndrome in children (MIS-C)
100%
Intravenous Immunoglobulin (IVIg)
100%
Adjusted Odds Ratio
30%
Disease Severity
30%
Confidence Interval
20%
Inotropic Support
20%
Biological Agents
10%
Mechanical Ventilation
10%
Web Database
10%
Organ Failure
10%
Organ Inflammation
10%
Generalized Linear Model
10%
Ventilatory Support
10%
COVID-19
10%
Observational Cohort Study
10%
Immunomodulatory Therapy
10%
Treatment Decisions
10%
Treatment Course
10%
World Health Organization Criteria
10%
Treatment Combination
10%
Ordinal Scale
10%
Inverse Probability Weighting
10%
Treatment Escalation
10%
Medicine and Dentistry
Serositis
100%
Glucocorticoid
100%
Immunoglobulin
100%
Odds Ratio
30%
Disease Severity
30%
Inotropism
20%
Biological Product
10%
Artificial Respiration
10%
Cohort Study
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Glucocorticoid
100%
Immunoglobulin
100%
Disease Severity
30%
Biological Product
10%
Cohort Study
10%
SARS Coronavirus
10%
Immunology and Microbiology
Intravenous Immunoglobulin
100%
Glucocorticoid
100%
Inotropism
20%
Biological Product
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Neuroscience
Glucocorticoid
100%
Intravenous Immunoglobulin
100%
Mechanical Ventilation
10%
SARS Coronavirus
10%
Generalized Linear Model
10%